Dennison, Elaine M. http://orcid.org/0000-0002-3048-4961
Laskou, Faidra
Westbury, Leo D.
Bevilacqua, Gregorio
Fuggle, Nicholas R.
Iidaka, Toshiko
Horii, Chiaki
Tanaka, Sakae
Yoshimura, Noriko
Cooper, Cyrus
Funding for this research was provided by:
Sasakawa Memorial Health Foundation (5365)
Article History
Received: 11 July 2023
Accepted: 1 November 2023
First Online: 10 November 2023
Declarations
:
: ED declares consultancy and speaker fees from Viatris, Pfizer, UCB and Lilly. CC has received lecture fees and honoraria from Amgen, Danone, Eli Lilly, GSK, Kyowa Kirin, Medtronic, Merck, Nestlé, Novartis, Pfizer, Roche, Servier, Shire, Takeda and UCB outside of the submitted work. NF declares travel bursaries from Pfizer and Eli Lilly. The remaining authors declare that they have no conflicts of interest.
: The research used data from human participants and was performed in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Ethical approval for the UK cohort was granted by the Hertfordshire Research Ethics Committee, reference number 10/H0311/59. Ethical approval for the Japanese cohort was granted by the ethics committees of the University of Tokyo (No. 1264 and No. 1326) and Wakayama Medical University (No. 373).
: All participants fully consented prior to undertaking the study.